These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10803470)

  • 1. Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome.
    Fatti LM; Bottasso B; Invitti C; Coppola R; Cavagnini F; Mannucci PM
    J Endocrinol Invest; 2000 Mar; 23(3):145-50. PubMed ID: 10803470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in coagulation indexes and occurrence of venous thromboembolism in patients with Cushing's syndrome: results from a prospective study before and after surgery.
    Manetti L; Bogazzi F; Giovannetti C; Raffaelli V; Genovesi M; Pellegrini G; Ruocco L; Iannelli A; Martino E
    Eur J Endocrinol; 2010 Nov; 163(5):783-91. PubMed ID: 20696792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels.
    Erem C; Nuhoglu I; Yilmaz M; Kocak M; Demirel A; Ucuncu O; Onder Ersoz H
    J Endocrinol Invest; 2009 Feb; 32(2):169-74. PubMed ID: 19411818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypercoagulability in Cushing's syndrome: the role of specific haemostatic and fibrinolytic markers.
    Kastelan D; Dusek T; Kraljevic I; Polasek O; Giljevic Z; Solak M; Salek SZ; Jelcic J; Aganovic I; Korsic M
    Endocrine; 2009 Aug; 36(1):70-4. PubMed ID: 19381886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of haemostatic and fibrinolytic markers in patients with Cushing's syndrome and in patients with adrenal incidentaloma.
    Ambrosi B; Sartorio A; Pizzocaro A; Passini E; Bottasso B; Federici A
    Exp Clin Endocrinol Diabetes; 2000; 108(4):294-8. PubMed ID: 10961361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome.
    Ames PR; Lupoli S; Alves J; Atsumi T; Edwards C; Iannaccone L; Khamashta MA; Hughes GR; Brancaccio V
    Br J Rheumatol; 1997 Oct; 36(10):1045-50. PubMed ID: 9374919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired microvascular reactivity and endothelial function in patients with Cushing's syndrome: influence of arterial hypertension.
    Prázný M; Ježková J; Horová E; Lazárová V; Hána V; Kvasnicka J; Pecen L; Marek J; Skrha J; Krsek M
    Physiol Res; 2008; 57(1):13-22. PubMed ID: 17223725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
    Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
    Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
    van der Pas R; de Bruin C; Leebeek FW; de Maat MP; Rijken DC; Pereira AM; Romijn JA; Netea-Maier RT; Hermus AR; Zelissen PM; de Jong FH; van der Lely AJ; de Herder WW; Lamberts SW; Hofland LJ; Feelders RA
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1303-10. PubMed ID: 22278425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?
    Koutroumpi S; Spiezia L; Albiger N; Barbot M; Bon M; Maggiolo S; Gavasso S; Simioni P; Frigo A; Mantero F; Scaroni C
    Pituitary; 2014 Feb; 17(1):68-75. PubMed ID: 23408210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Von Willebrand factor and fibrinolytic parameters during the desmopressin test in patients with Cushing's disease.
    Pecori Giraldi F; Ambrogio AG; Fatti LM; Rubini V; Cozzi G; Scacchi M; Federici AB; Cavagnini F
    Br J Clin Pharmacol; 2011 Jan; 71(1):132-6. PubMed ID: 21143510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome.
    Casonato A; Pontara E; Boscaro M; Sonino N; Sartorello F; Ferasin S; Girolami A
    Blood Coagul Fibrinolysis; 1999 Apr; 10(3):145-51. PubMed ID: 10357009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Coagulation, Fibrinolysis and Endothelial Biomarkers in Cirrhotic Patients With or Without Portal Venous Thrombosis.
    Ren W; Zhang J; Chen Y; Wen M; Su Y; Zhao Y; Lu S; Wu J
    Clin Appl Thromb Hemost; 2020; 26():1076029620982666. PubMed ID: 33356499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.
    Patrassi GM; Sartori MT; Viero ML; Scarano L; Boscaro M; Girolami A
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):789-93. PubMed ID: 1489900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of procoagulant imbalance in Cushing's syndrome after short- and long-term remission of disease.
    Ferrante E; Serban AL; Clerici M; Indirli R; Scalambrino E; Carosi G; Padovan L; Locatelli M; Arosio M; Peyvandi F; Mantovani G; Tripodi A
    J Endocrinol Invest; 2022 Jan; 45(1):9-16. PubMed ID: 34115342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercoagulable state in Cushing's syndrome: a systematic review.
    Van Zaane B; Nur E; Squizzato A; Dekkers OM; Twickler MT; Fliers E; Gerdes VE; Büller HR; Brandjes DP
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2743-50. PubMed ID: 19454584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Arterial Procedures on Coagulation and Fibrinolysis - A Pilot Study.
    Polok KJ; Górka J; Fronczek J; Górka K; Kaczmarek B; Iwaniec T; Iwaszczuk P; Musiał J; Szczeklik W
    Braz J Cardiovasc Surg; 2019 Jun; 34(3):327-334. PubMed ID: 31310472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysis.
    van Geffen M; Loof A; Lap P; Boezeman J; Laros-van Gorkom BA; Brons P; Verbruggen B; van Kraaij M; van Heerde WL
    Hematology; 2011 Nov; 16(6):327-36. PubMed ID: 22183066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.